What tests should be done for breast cancer

Generally speaking, the most basic examinations for breast cancer are breast color Doppler ultrasound and mammography. Color Doppler ultrasound is generally the most practical and effective examination method. Color Doppler ultrasound can detect breast nodules and determine their grade. Generally speaking, lesions above grade 4 are malignant, and breast mammography is one of the most effective imaging examination methods. At the same time, in order to further clarify the pathological examination or hollow needle puncture examination. The gold standard for breast cancer diagnosis is the detection of cancer cells during pathological examination. After the diagnosis of breast cancer is confirmed, a comprehensive treatment strategy should be selected according to the tumor stage and molecular classification.

How is mucinous breast cancer treated?

Mucinous breast cancer is a type of breast cancer. Breast cancer is generally a common malignancy in women, but it is not exclusive to women. Breast cancer can also occur in men. Generally speaking, mucinous breast cancer is more common in women and may begin to manifest as a painless breast lump. As the disease progresses, axillary lymph node metastasis may occur. In this case, mucinous breast cancer can be diagnosed through surgery and pathological examination. Generally speaking, radical surgery and axillary lymph node cleaning should also be combined with comprehensive anti-tumor treatment, because breast cancer is also a systemic disease.

Is breast cancer curable?

This depends on the stage and pathological classification of breast cancer. Early breast cancer, then early surgical treatment, combined with comprehensive anti-tumor treatment such as radiotherapy, chemotherapy, endocrine therapy, targeted drug therapy, etc., can achieve long-term survival. For example, those who survived for five years, ten years or even longer. But if it is some pathological classification, the malignancy is relatively high, such as triple-negative breast cancer and other widely metastatic sites. It is not easy to treat, and the treatment effect is relatively poor.